These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11179527)
21. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Stampfuss J; Kubitza D; Becka M; Mueck W Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226 [TBL] [Abstract][Full Text] [Related]
22. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions. Guivarc'h PH; Vachon MG; Fordyce D Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008 [TBL] [Abstract][Full Text] [Related]
24. Effect of food on the bioavailability of adinazolam from a sustained release formulation: effect of meal timing and lack of dose dumping. Fleishaker JC; Phillips JP; Lau HS Biopharm Drug Dispos; 1990 Nov; 11(8):715-27. PubMed ID: 2271747 [TBL] [Abstract][Full Text] [Related]
25. [Amiodarone administered orally or intravenously - the same or different drug?]. Kosior DA; Krzykwa A; Postuła M Pol Merkur Lekarski; 2013 Apr; 34(202):183-7. PubMed ID: 23745321 [TBL] [Abstract][Full Text] [Related]
26. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers. Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372 [TBL] [Abstract][Full Text] [Related]
27. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration. Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768 [TBL] [Abstract][Full Text] [Related]
28. Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tablet. Martinez MN; Pelsor FR; Shah VP; Skelly JP; Honigberg IL; Hemingway SM; Gallo JM; Kotzan JA; Zaman R; Brown WJ Biopharm Drug Dispos; 1990; 11(1):17-29. PubMed ID: 2322634 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone. Shayeganpour A; Hamdy DA; Brocks DR Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885 [TBL] [Abstract][Full Text] [Related]
30. Disposition of intravenous amiodarone in subjects with normal and impaired renal function. Ujhelyi MR; Klamerus KJ; Vadiei K; O'Rangers E; Izard M; Neefe DL; Zimmerman JJ; Chow MS J Clin Pharmacol; 1996 Feb; 36(2):122-30. PubMed ID: 8852388 [TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects. Helmy SA; El Bedaiwy HM Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169 [TBL] [Abstract][Full Text] [Related]
32. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials. Devarakonda K; Kostenbader K; Giuliani MJ; Young JL BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499 [TBL] [Abstract][Full Text] [Related]
33. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297 [TBL] [Abstract][Full Text] [Related]
34. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
35. Effect of food on bioavailability of nalidixic acid from uncoated tablets having different dissolution rates. Ogata H; Aoyagi N; Kaniwa N; Ejima A J Pharmacobiodyn; 1984 Oct; 7(10):760-7. PubMed ID: 6520698 [TBL] [Abstract][Full Text] [Related]
36. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689 [TBL] [Abstract][Full Text] [Related]
39. Absolute bioavailability of amiodarone in normal subjects. Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454 [TBL] [Abstract][Full Text] [Related]